Idorsia Ltd (SWX:IDIA)

Switzerland · Delayed Price · Currency is CHF

3.695

-0.170 (-4.40%)

Feb 20, 2026, 5:31 PM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Discovering, Developing and Commercializing Drugs	112.51M	152.39M	97.10M	35.35M	71.76M
Discovering, Developing and Commercializing Drugs Growth	-26.17%	56.93%	174.70%	-50.74%	201.26%
Total	112.51M	152.39M	97.10M	35.35M	71.76M
Total Growth	-26.17%	56.93%	174.70%	-50.74%	201.26%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	28.60M	24.41M	5.54M	-	-
United States Growth	17.17%	340.36%	-	-	-
Switzerland	51.11M	88.03M	46.58M	35.35M	71.76M
Switzerland Growth	-41.94%	88.99%	31.77%	-50.74%	201.26%
EUCAN	29.27M	6.28M	1.00M	-	-
EUCAN Growth	365.79%	525.90%	-	-	-
Japan	3.53M	33.66M	43.98M	-	-
Japan Growth	-89.53%	-23.45%	-	-	-
Total	112.51M	152.39M	97.10M	35.35M	71.76M
Total Growth	-26.17%	56.93%	174.70%	-50.74%	201.26%

Source: S&P Global Market Intelligence.